English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51771683    ???header.onlineuser??? :  1151
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"pei jer chen"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 586-595 of 883  (89 Page(s) Totally)
<< < 54 55 56 57 58 59 60 61 62 63 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:33:49Z Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response Hong C.-M.; Liu C.-J.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:49Z Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047)) Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏 2021-07-03T03:33:49Z Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; Liu C.-J.; Huang C.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Yu M.-W.
臺大學術典藏 2021-07-03T03:33:48Z A phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma Yau T.C.C.; Lencioni R.; Sukeepaisarnjaroen W.; Chao Y.; Yen C.-J.; Lausoontornsiri W.; PEI-JER CHEN; Sanpajit T.; Camp A.; Cox D.S.; Gagnon R.C.; Liu Y.; Raffensperger K.E.; Kulkarni D.A.; Kallender H.; Ottesen L.H.; Poon R.T.P.; Bottaro D.P.
臺大學術典藏 2021-07-03T03:33:48Z De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline Lin Y.-Y.; Hsieh C.-H.; Chen J.-H.; Lu X.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.; Wang H.-Y.
臺大學術典藏 2021-07-03T03:33:48Z Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study Lu L.-C.; PEI-JER CHEN; Yeh Y.-C.; Hsu C.-H.; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:33:47Z Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007)) Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏 2021-07-03T03:33:47Z Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Chiang C.-L.; Wu J.-F.; Chen H.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:47Z Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Omata M.; Cheng A.-L.; Kokudo N.; Kudo M.; Lee J.M.; Jia J.; Tateishi R.; Han K.-H.; Chawla Y.K.; Shiina S.; Jafri W.; Payawal D.A.; Ohki T.; Ogasawara S.; PEI-JER CHEN; Lesmana C.R.A.; Lesmana L.A.; Gani R.A.; Obi S.; Dokmeci A.K.; Sarin S.K.
臺大學術典藏 2021-07-03T03:33:47Z Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients Phillips S.; Mistry S.; Riva A.; Cooksley H.; Hadzhiolova-Lebeau T.; Plavova S.; Katzarov K.; Simonova M.; Zeuzem S.; Woffendin C.; PEI-JER CHEN; Peng C.-Y.; Chang T.-T.; Lueth S.; Knegt R.D.; Choi M.-S.; Wedemeyer H.; Dao M.; Kim C.-W.; Chu H.-C.; Wind-Rotolo M.; Williams R.; Cooney E.; Chokshi S.

Showing items 586-595 of 883  (89 Page(s) Totally)
<< < 54 55 56 57 58 59 60 61 62 63 > >>
View [10|25|50] records per page